NOTE: As provided in LFC policy, this report is
intended only for use by the standing finance committees of the
legislature. The Legislative Finance Committee does not assume
responsibility for the accuracy of the information in this report when used for
other purposes.
The most recent FIR
version (in HTML & Adobe PDF formats) is available on the Legislative
Website. The Adobe PDF version includes
all attachments, whereas the HTML version does not. Previously issued FIRs and attachments may be
obtained from the LFC in
SPONSOR: |
Lujan, B |
DATE TYPED: |
|
HB |
939 |
||
SHORT TITLE: |
Subcontractor Minimum Dispensing Fee |
SB |
|
||||
|
ANALYST: |
Weber |
|||||
APPROPRIATION
Appropriation
Contained |
Estimated
Additional Impact |
Recurring or
Non-Rec |
Fund Affected |
||
FY03 |
FY04 |
FY03 |
FY04 |
|
|
|
$0.0 |
|
|
|
|
|
|
|
|
|
|
(Parenthesis
( ) Indicate Expenditure Decreases)
Responses
Received From
Human Services Department
Regulation and Licensing Department-Pharmacy
Board
SUMMARY
Synopsis
of Bill
House
Bill 939 (HB 939) seeks to amend the language in Section
Significant
Issues
HB
939 would allow the Managed Care Organization (MCOs),
and any other subcontractor for HSD, to negotiate appropriate dispensing fees
based on rural or urban needs and difficult to serve populations, and may offers
providers incentives to serve underserved areas and populations.
This
would increase the flexibility of the contractors and HSD allowing for higher
dispensing fees when necessary, and lower when appropriate.
This
would eliminate HSD involvement in the ongoing Starko
Lawsuit.
FISCAL IMPLICATIONS
Specific fiscal
implications are indeterminate, but there be would impact on Medicaid pharmacy
costs.
MW/ls